References analysis of the Wikipedia article "Бекерова мишићна дистрофија" in the Serbian version

doi.org

Andrews, J. G.; Wahl, R. A. (2018). „Duchenne and Becker muscular dystrophy in adolescents: current perspectives”. Adolesc Health Med Ther. 9: 53—63. PMC 5858539 

. PMID 29588625. doi:10.2147/AHMT.S125739 

Romitti, P. A.; Zhu, Y.; Puzhankara, S.; et al. (2015). „Prevalence of Duchenne and Becker muscular dystrophies in the United States”. Pediatrics. 135 (3): 513—521. PMC 4477633 

. PMID 25687144. doi:10.1542/peds.2014-2044..

Daoud, F.; Angeard, N.; Demerre, B.; Martie, I.; Benyaou, R.; Leturcq, F.; Cossee, M.; Deburgrave, N.; Saillour, Y.; Tuffery, S.; Urtizberea, A.; Toutain, A.; Echenne, B.; Frischman, M.; Mayer, M.; Desguerre, I.; Estournet, B.; Reveillere, C.; Penisson-Besnier; Cuisset, J. M.; Kaplan, J. C.; Heron, D.; Rivier, F.; Chelly, J. (2009). „Analysis of Dp71 contribution in the severity of mental retardation through comparison of Duchenne and Becker patients differing by mutation consequences on Dp71 expression”. Human Molecular Genetics. 18 (20): 3779—3794. PMID 19602481. doi:10.1093/hmg/ddp320..

Robinson-Hamm, Jacqueline N.; Gersbach, Charles A. (2016). „Gene therapies that restore dystrophin expression for the treatment of Duchenne muscular dystrophy”. Human Genetics. 135 (9): 1029—1040. PMC 5006996 

. PMID 27542949. doi:10.1007/s00439-016-1725-z.

Francis, M. J.; Morrison, K. M.; Campbell, L; Grewal, P. K.; Christodoulou, Z; Daniels, R. J.; et al. (1993). „A contig of non-chimeric YACs containing the spinal muscular atrophy gene in 5ql3”. Hum Mol Genet. 2 (8): 1161—7. PMID 8401497. doi:10.1093/hmg/2.8.1161..

Oudet C, Hanauer A, Clemens P, Caskey CT, Mandel JL (1992). „Two hot spots of recombination in the DMD-gene correlate with the deletion prone regions”. Hum Mol Genet. 1 (8): 599—603. PMID 1363782. doi:10.1093/hmg/1.8.599..

Guiraud, Simon; Edwards, Benjamin; Babbs, Arran; Squire, Sarah E.; Berg, Adam; Moir, Lee; Wood, Matthew J.; Davies, Kay E. (2019). „The potential of utrophin and dystrophin combination therapies for Duchenne muscular dystrophy”. Human Molecular Genetics. 28 (13): 2189—2200. PMC 6586144 

. PMID 30990876. doi:10.1093/hmg/ddz049..

Nigro G, Comi LI, Politano L, Bain RJ (1990). „The incidence and evolution of cardiomyopathy in Duchenne muscular dystrophy”. Int J Cardiol. 26 (3): 271—277. PMID 2312196. doi:10.1016/0167-5273(90)90082-G.

Melacini, P.; Fanin, M.; Danieli, G.A.; Villanova, C.; Martinello, F.; Miorin, M.; Freda, M.P.; Miorelli, M.; Mostacciuolo, M.L.; Fasoli, G.; Angelini, C.; Volta, S. Dalla (1996). „Myocardial Involvement is Very Frequent Among Patients Affected with Subclinical Becker's Muscular Dystrophy”. Circulation. 94 (12): 3168—3175. PMID 8989125. doi:10.1161/01.CIR.94.12.3168.

Yazawa, Masanobu; Ikeda, Shu-Ichi; Owa, Mafumi; Haruta, Sei-Ichi; Yanagisawa, Nobuo; Tanaka, Eiji; Watanabe, Masahide (1987). „A Family of Becker's Progressive Muscular Dystrophy with Severe Cardiomyopathy”. European Neurology. 27 (1): 13—19. PMID 3622571. doi:10.1159/000116122..

Connuck, D. M.; Sleeper, L. A.; Colan, S. D.; et al. (2008). „Characteristics and outcomes of cardiomyopathy in children with Duchenne or Becker muscular dystrophy: a comparative study from the Pediatric Cardiomyopathy Registry”. American Heart Journal. 155 (6): 998—1005. PMC 2729548 

. PMID 18513510. doi:10.1016/j.ahj.2008.01.018.

Papa, A. A.; d'Ambrosio, P.; Petillo, R.; Palladino, A.; Politano, L. (2017). „Heart transplantation in patients with dystrophinopathic cardiomyopathy: review of the literature and personal series”. Intractable Rare Dis Res. 6 (2): 95—101. PMC 5451754 

. PMID 28580208. doi:10.5582/irdr.2017.01024.

Bradley, W. G.; Jones, M. Z.; Mussini, J-M; Fawcett, P. R. W. (1978). „Becker-type muscular dystrophy”. Muscle and Nerve. 1 (2): 111—132. PMID 571527. S2CID 9758645. doi:10.1002/mus.880010204.

Ruiz-Cano, M.J.; Delgado, J.F.; Jiménez, C.; Jiménez, S.; Cea-Calvo, L.; Sánchez, V.; Escribano, P.; Gómez, M.A.; Gil-Fraguas, L.; Sáenz de la Calzada, C. (2003). „Successful heart transplantation in patients with inherited myopathies associated with end-stage cardiomyopathy”. Transplantation Proceedings. 35 (4): 1513—1515. PMID 12826208. doi:10.1016/S0041-1345(03)00515-3.

Ricotti, Valeria; Mandy, William P L.; Scoto, Mariacristina; Pane, Marika; Deconinck, Nicolas; Messina, Sonia; Mercuri, Eugenio; Skuse, David H.; Muntoni, Francesco (2016). „Neurodevelopmental, emotional, and behavioural problems in Duchenne muscular dystrophy in relation to underlying dystrophin gene mutations”. Developmental Medicine & Child Neurology. 58 (1): 77—84. PMID 26365034. S2CID 24157176. doi:10.1111/dmcn.12922..

Passos-Bueno MR, Vainzof M, Zatz M (1994). „Half the dystrophin gene is apparently enough for a mild clinical course: confirmation of its poten- tial use for gene therapy”. Hum Mol Genet. 3 (6): 919—22. PMID 7951237. doi:10.1093/hmg/3.6.919..

Ho, Rady; Nguyen, My-Le; Mather, Paul (2016). „Cardiomyopathy in becker muscular dystrophy: Overview”. World Journal of Cardiology. 8 (6): 356—361. PMC 4919702 

. PMID 27354892. doi:10.4330/wjc.v8.i6.356 

Bushby, K. M. D.; Gardner-Medwin, D. (1993). „The clinical, genetic and dystrophin characteristics of Becker muscular dystrophy”. Journal of Neurology. 240 (2): 98—104. PMID 8437027. S2CID 34640103. doi:10.1007/BF00858725..

Peverelli, Lorenzo; Testolin, Silvia; Villa, Luisa; d'Amico, Adele; Petrini, Stefania; Favero, Chiara; Magri, Francesca; Morandi, Lucia; Mora, Marina; Mongini, Tiziana; Bertini, Enrico; Sciacco, Monica; Comi, Giacomo P.; Moggio, Maurizio (2015). „Histologic muscular history in steroid-treated and untreated patients with Duchenne dystrophy”. Neurology. 85 (21): 1886—1893. PMC 4662699 

. PMID 26497992. doi:10.1212/WNL.0000000000002147.

Bell, C.D.; Conen, P.E. (1968). „Histopathological changes in Duchenne muscular dystrophy”. Journal of the Neurological Sciences. 7 (3): 529—544. PMID 5709861. doi:10.1016/0022-510X(68)90058-0.

Desguerre, Isabelle; Mayer, Michelle; Leturcq, France; Barbet, Jacques-Patrick; Gherardi, Romain K.; Christov, Christo (2009). „Endomysial Fibrosis in Duchenne Muscular Dystrophy: A Marker of Poor Outcome Associated with Macrophage Alternative Activation”. Journal of Neuropathology & Experimental Neurology. 68 (7): 762—773. PMID 19535995. S2CID 26182671. doi:10.1097/NEN.0b013e3181aa31c2..

Duboc, Denis; Meune, Christophe; Lerebours, Guy; Devaux, Jean-Yves; Vaksmann, Guy; Bécane, Henri-Marc (2005). „Effect of perindopril on the onset and progression of left ventricular dysfunction in Duchenne muscular dystrophy”. Journal of the American College of Cardiology. 45 (6): 855—857. PMID 15766818. doi:10.1016/j.jacc.2004.09.078..

Johnsen, Stanley D.; Clinic, Blue Bird (2001). „Prednisone Therapy in Becker's Muscular Dystrophy”. Journal of Child Neurology. 16 (11): 870—871. PMID 11732779. S2CID 35098650. doi:10.1177/08830738010160111406..

mda.org

„Diseases - BMD - Top Level”. Muscular Dystrophy Association (на језику: енглески). 2015-12-18. Приступљено 2021-02-01.

„Diseases - BMD - Research”. Muscular Dystrophy Association (на језику: енглески). 2015-12-18. Приступљено 2021-02-01.

„Diseases - BMD - Diagnosis”. Muscular Dystrophy Association (на језику: енглески). 2015-12-18. Приступљено 2021-02-01.

„Diseases - BMD - Signs & Symptoms”. Muscular Dystrophy Association (на језику: енглески). 2015-12-18. Приступљено 2021-02-01.

„Diseases - BMD - Medical Management”. Muscular Dystrophy Association (на језику: енглески). 2015-12-18. Приступљено 2021-02-01.

nih.gov